A Molecular Mechanism for Therapeutic Effects of cGMP-elevating Agents in Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

A Molecular Mechanism for Therapeutic Effects of cGMP-elevating Agents in Pulmonary Arterial Hypertension

Published:2013-06 Issue:23 Volume:288 Page:16557-16566
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Schwappacher Raphaela,Kilic Ana,Kojonazarov Baktybek,Lang Michaela,Diep Thuan,Zhuang Shunhui,Gawlowski Thomas,Schermuly Ralph T.,Pfeifer Alexander,Boss Gerry R.,Pilz Renate B.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference48 articles.

1. Mechanisms of disease: pulmonary arterial hypertension;Schermuly;Nat. Rev. Cardiol,2011

2. Molecular pathogenesis of pulmonary arterial hypertension;Rabinovitch;J. Clin. Invest,2008

3. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype;Boerth;J. Vasc. Res,1997

4. Molecular regulation of vascular smooth muscle cell differentiation in development and disease;Owens;Physiol. Rev,2004

5. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats;Lang;PLoS One,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitric oxide regulation of fetal and newborn lung development and function;Nitric Oxide;2024-06

2. Activating NO–sGC crosstalk in the mouse vascular niche promotes vascular integrity and mitigates acute lung injury;Journal of Experimental Medicine;2022-11-09

3. Role of NO-cGMP-PKG axis in pulmonary arterial hypertension;Folia Pharmacologica Japonica;2022

4. Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway;Frontiers in Pharmacology;2021-11-12

5. Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension;Pulmonary Circulation;2021-07